Suk M Ko, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Offices
- 2
Offices
2 locations · University Healthcare Alliance · Indian Health Center of Santa Clara Valley
Hospitals listed: Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ko’s office at (408) 995-5453 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A171668 · Current
Licensed to practise in California · since 2021 · expires 2027-02-28 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$84,058
Medicare paid this office $84,058 for 235 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 135 | $26,837 | $103 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 79 | $12,093 | $153 |
| Long return visit (40+ min) | 41 | $7,780 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $5,123 | $63 |
| Sarscov2 vac 50 mcg/0.5ml im | 27 | $4,614 | $154 |
See all 13 services
| Return visit (30+ min) | 135 | $26,837 | $103 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 79 | $12,093 | $153 |
| Long return visit (40+ min) | 41 | $7,780 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $5,123 | $63 |
| Sarscov2 vac 50 mcg/0.5ml im | 27 | $4,614 | $154 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 148 | $3,864 | $13 |
| Short return visit (20+ min) | 51 | $3,487 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,260 | $108 |
| Influenza vaccine split virus, preservative free | 24 | $1,964 | $82 |
| Admn sarscov2 vacc 1 dose | 27 | $1,563 | $52 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,217 | $61 |
| Administration of influenza virus vaccine | 26 | $994 | $38 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 12 | $917 | $48 |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
235 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 12% · Women 37% · Also on Medicaid 17% · Health risk score 1.16. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 73% · Diabetes 30% · Coronary heart disease 28% · Chronic kidney disease 21% · Depression 20% · Cancer 19% · Atrial fibrillation 17% · Heart failure 15% · Dementia 11% · COPD 9% · Stroke 8%.
The office billed $306,013, Medicare allowed $111,430 and paid $84,058; for 1,327 services of 51 kinds; $11,357 of it was for drugs given in the office and $72,701 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 235 | 1,327 | 74 | 1.16 | $306,013 | $84,058 |
| 2023 | 223 | 844 | 74 | 1.77 | $268,763 | $74,351 |
| 2022 | 196 | 515 | 74 | 1.28 | $190,392 | $52,116 |
| 2021 | 78 | 139 | 73 | 0.88 | $50,049 | $13,621 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 95 | $21,270 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $10,927 | $68 |
| Long return visit (40+ min) | 30 | $9,358 | $167 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $5,385 | $117 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $4,677 | $156 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 16 | $4,517 | $282 |
| Hospital discharge day management, 30 minutes or less | 46 | $3,385 | $74 |
| Short return visit (20+ min) | 45 | $3,134 | $60 |
| Influenza vaccine split virus, preservative free | 17 | $1,223 | $72 |
| Administration of influenza virus vaccine | 21 | $850 | $37 |
| Administration of pneumococcal vaccine | 16 | $591 | $37 |
2022: 12 services
| Return visit (30+ min) | 94 | $14,765 | $109 |
| Long return visit (40+ min) | 26 | $6,291 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $5,649 | $96 |
| New patient visit (45+ min) | 27 | $4,017 | $149 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 13 | $3,632 | $279 |
| Short return visit (20+ min) | 34 | $2,843 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,512 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,624 | $116 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,254 | $66 |
| Influenza vaccine split virus, preservative free | 11 | $725 | $66 |
| Administration of pneumococcal vaccine | 19 | $713 | $38 |
| Administration of influenza virus vaccine | 16 | $573 | $36 |
2021: 3 services
| Return visit (30+ min) | 26 | $3,574 | $112 |
| Short return visit (20+ min) | 23 | $2,179 | $87 |
| New patient visit (45+ min) | 13 | $1,933 | $149 |
Medicaid work
$141,387 in 2024
Medicaid paid $141,387 for 1,218 billed services this clinician did in 2024, up to 84 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 529 | $134,415 |
| Short return visit (20+ min) | 399 | $3,428 |
| Return visit (30+ min) | 62 | $944 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 14 | $934 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 31 | $651 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 100 | $639 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 22 | $260 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 18 | $116 |
| Service | 43 | $0 |
| 2024 | 1,218 | 9 | 84 | $141,387 |
| 2023 | 1,102 | 8 | 68 | $116,213 |
| 2022 | 940 | 8 | 68 | $72,829 |
| 2021 | 185 | 2 | 52 | $19,232 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 460 | $110,651 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 151 | $2,118 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 51 | $1,376 |
| Short return visit (20+ min) | 292 | $967 |
| Service | 12 | $516 |
| Return visit (30+ min) | 109 | $316 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 13 | $270 |
| Service | 14 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 323 | $69,471 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 28 | $856 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 42 | $787 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 28 | $732 |
| Short return visit (20+ min) | 314 | $485 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 15 | $282 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 177 | $216 |
| Service | 13 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 91 | $19,099 |
| Short return visit (20+ min) | 94 | $133 |
Drugs they prescribed that Part D paid
$119,821
Pharmacies billed $119,821 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (12 of 1,288) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,154 generic and fewer than 11 brand-name prescriptions · $119,821 in drug cost · 59 antibiotic prescriptions to 41 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 22 | $25,395 | $1,154 |
| Jardiance | 12 | $19,222 | $1,602 |
| Eliquis | 11 | $7,533 | $685 |
| Tamsulosin | 71 | $1,429 | $20 |
| Atorvastatin | 111 | $1,114 | $10 |
See all 29 drugs
| Ozempic | 22 | $25,395 | $1,154 |
| Jardiance | 12 | $19,222 | $1,602 |
| Eliquis | 11 | $7,533 | $685 |
| Tamsulosin | 71 | $1,429 | $20 |
| Atorvastatin | 111 | $1,114 | $10 |
| Amlodipine Besylate | 69 | $937 | $14 |
| Rosuvastatin | 51 | $864 | $17 |
| Olmesartan Medoxomil | 21 | $585 | $28 |
| Gabapentin | 27 | $534 | $20 |
| Valsartan | 17 | $517 | $30 |
| Losartan | 65 | $506 | $8 |
| Metformin Hcl Er | 21 | $473 | $23 |
| Pravastatin | 32 | $473 | $15 |
| Levothyroxine | 45 | $458 | $10 |
| Alfuzosin Hcl Er | 13 | $425 | $33 |
| Famotidine | 12 | $371 | $31 |
| Finasteride | 16 | $266 | $17 |
| Simvastatin | 23 | $235 | $10 |
| Metoprolol | 17 | $206 | $12 |
| Metformin | 38 | $180 | $5 |
| Lisinopril | 26 | $154 | $6 |
| Amoxicillin-Clavulanate Potass | 16 | $147 | $9 |
| Triamcinolone Acetonide | 18 | $114 | $6 |
| Zolpidem | 14 | $105 | $8 |
| Trazodone | 19 | $98 | $5 |
| Sertraline | 18 | $89 | $5 |
| Hydrochlorothiazide | 15 | $67 | $4 |
| Azithromycin | 12 | $47 | $4 |
| Allopurinol | 13 | $27 | $2 |
Year by year
| 2024 | 1,288 | 204 | 1% (12) | None | $119,821 |
| 2023 | 960 | 156 | 2% (22) | 12% | $104,317 |
| 2022 | 525 | 126 | None | 10% | $25,784 |
| 2021 | 310 | 67 | None | None | $42,081 |
| 2020 | 464 | 56 | None | None | $46,681 |
| 2019 | 350 | 75 | None | None | $22,329 |
| 2018 | 183 | 48 | None | None | $7,896 |
| 2017 | 30 | None | 0% (0) | None | $741 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Eliquis | 12 | $7,158 | $596 |
| Stiolto Respimat | 11 | $5,564 | $506 |
| Atorvastatin | 85 | $1,145 | $13 |
| Tamsulosin | 43 | $1,042 | $24 |
| Losartan | 65 | $657 | $10 |
| Quetiapine | 12 | $601 | $50 |
| Amlodipine Besylate | 43 | $410 | $10 |
| Gabapentin | 18 | $393 | $22 |
| Levothyroxine | 26 | $306 | $12 |
| Pravastatin | 12 | $290 | $24 |
| Metformin | 21 | $238 | $11 |
| Metformin Hcl Er | 15 | $230 | $15 |
| Rosuvastatin | 19 | $226 | $12 |
| Spironolactone | 16 | $209 | $13 |
| Nitrofurantoin Mono-Macro | 12 | $182 | $15 |
| Triamcinolone Acetonide | 15 | $175 | $12 |
| Paxlovid (Eua) | 16 | $148 | $9 |
| Amoxicillin-Clavulanate Potass | 19 | $147 | $8 |
| Finasteride | 12 | $142 | $12 |
| Lisinopril | 11 | $88 | $8 |
| Tramadol | 12 | $79 | $7 |
| Furosemide | 11 | $62 | $6 |
2022: 14 drugs
| Eliquis | 15 | $9,544 | $636 |
| Levothyroxine | 21 | $402 | $19 |
| Tamsulosin | 23 | $318 | $14 |
| Diltiazem 24hr Er (Cd) | 12 | $303 | $25 |
| Losartan | 28 | $302 | $11 |
| Atorvastatin | 28 | $277 | $10 |
| Metoprolol | 15 | $262 | $17 |
| Enalapril Maleate | 12 | $244 | $20 |
| Isosorbide Mononitrate Er | 12 | $171 | $14 |
| Paxlovid (Eua) | 16 | $132 | $8 |
| Amlodipine Besylate | 19 | $119 | $6 |
| Spironolactone | 14 | $97 | $7 |
| Furosemide | 19 | $95 | $5 |
| Metformin | 18 | $84 | $5 |
2021: 8 drugs
| Symbicort | 12 | $6,201 | $517 |
| Albuterol Sulfate Hfa | 18 | $917 | $51 |
| Atorvastatin | 28 | $382 | $14 |
| Pantoprazole | 15 | $254 | $17 |
| Metoprolol | 11 | $208 | $19 |
| Amlodipine Besylate | 14 | $131 | $9 |
| Metformin | 12 | $89 | $7 |
| Lisinopril | 15 | $50 | $3 |
2020: 13 drugs
| Tradjenta | 12 | $5,865 | $489 |
| Levemir | 13 | $4,216 | $324 |
| Symbicort | 11 | $4,170 | $379 |
| Gabapentin | 41 | $619 | $15 |
| Atorvastatin | 54 | $535 | $10 |
| Metoprolol | 16 | $288 | $18 |
| Amlodipine Besylate | 18 | $123 | $7 |
| Metformin | 23 | $106 | $5 |
| Losartan | 20 | $97 | $5 |
| Carvedilol | 11 | $88 | $8 |
| Lisinopril | 20 | $80 | $4 |
| Sertraline | 12 | $44 | $4 |
| Citalopram Hbr | 13 | $26 | $2 |
2019: 6 drugs
| Atorvastatin | 37 | $525 | $14 |
| Gabapentin | 16 | $266 | $17 |
| Losartan | 19 | $151 | $8 |
| Ranitidine | 15 | $141 | $9 |
| Pantoprazole | 14 | $100 | $7 |
| Amlodipine Besylate | 12 | $79 | $7 |
2018: 3 drugs
| Atorvastatin | 19 | $517 | $27 |
| Gabapentin | 11 | $202 | $18 |
| Amlodipine Besylate | 12 | $117 | $10 |
Money from drug and device companies
$26 in 2025
| 2025 | 1 | 1 | None | $26 |
| 2019 | 1 | 1 | None | $12 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Bexsero | $26 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2025-08-02 | Bexsero | $26 |
See earlier years (2019)
2019: $12
| Alexion Pharmaceuticals | None | $12 | 1 payment
|
Professional record
- NPI
- 1932631736
- Licence
- CA A171668California A171668: Current · expires 2027-02-28
- Trained
- Stanford University School of Medicine, 2017
- Group
- University Healthcare Alliance · Indian Health Center of Santa Clara Valley
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 455 Oconnor Dr Ste 210, San Jose, CA, 95128
- NPI first listed
- 2017-03-30
- NPI last updated
- 2024-04-25
- NPI record certified
- 2024-04-25
This is when the NPI record was last certified, not a medical board exam.